William Rice
Chief Executive Officer at APTOSE BIOSCIENCES INC.
Net worth: 56 799 $ as of 2024-03-30
William Rice active positions
| Companies | Position | Start | End |
|---|---|---|---|
| APTOSE BIOSCIENCES INC. | Comptroller/Controller/Auditor | 2022-04-06 | - |
| Chief Executive Officer | 2013-10-27 | - | |
| Chairman | 2013-10-27 | - | |
| President | 2013-10-27 | - | |
Cylene Pharmaceuticals, Inc.
 Cylene Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Cylene Pharmaceuticals, Inc. discovers, develops and commercializes small molecule drugs. It develops molecule drugs to treat life-threatening diseases, with a particular emphasis in oncology. The firm drug discovery platform, STAND has delivered a diverse portfolio of drug candidates that target the multiple pathways critical for the support, maintenance of cancer cells and that address unmet medical needs with substantial markets. The company was founded in 1997 by Thomas James Farrell and Daniel Douglas Von Hoff and is headquartered in San Diego, CA. | Chairman | 2010-09-27 | - |
| Director/Board Member | 2010-09-27 | - | |
| Chief Executive Officer | 2002-12-31 | - | |
| President | 2002-12-31 | - |
Career history of William Rice
Former positions of William Rice
| Companies | Position | Start | End |
|---|---|---|---|
| ONCOLYTICS BIOTECH INC. | Director/Board Member | 2015-06-07 | 2020-12-31 |
| Independent Dir/Board Member | 2015-06-07 | 2020-12-31 | |
| ACHILLION PHARMACEUTICALS, INC. | Director/Board Member | 1998-08-16 | 2003-07-31 |
| Chief Executive Officer | 1998-08-16 | 2003-07-31 | |
| Founder | 1998-08-16 | 2003-07-31 | |
| President | 1998-08-16 | 2003-07-31 | |
| Frederick National Laboratory For Cancer Research | Corporate Officer/Principal | 1991-12-31 | 1997-12-31 |
| Emory University School of Medicine | Corporate Officer/Principal | 1988-12-31 | 1991-12-31 |
Training of William Rice
| Emory University | Doctorate Degree |
Statistics
International
| United States | 6 |
| Canada | 3 |
Operational
| Director/Board Member | 3 |
| Chief Executive Officer | 3 |
| President | 3 |
Sectoral
| Health Technology | 5 |
| Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 2 |
|---|---|
| APTOSE BIOSCIENCES INC. | Health Technology |
| ONCOLYTICS BIOTECH INC. | Health Technology |
| Private companies | 3 |
|---|---|
Cylene Pharmaceuticals, Inc.
Cylene Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Cylene Pharmaceuticals, Inc. discovers, develops and commercializes small molecule drugs. It develops molecule drugs to treat life-threatening diseases, with a particular emphasis in oncology. The firm drug discovery platform, STAND has delivered a diverse portfolio of drug candidates that target the multiple pathways critical for the support, maintenance of cancer cells and that address unmet medical needs with substantial markets. The company was founded in 1997 by Thomas James Farrell and Daniel Douglas Von Hoff and is headquartered in San Diego, CA. | Health Technology |
Achillion Pharmaceuticals, Inc.
 Achillion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Achillion Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of oral small molecule complement system inhibitors. Its pipeline includes Danicopan and ACH-5228. The company was founded on August 17, 1998 and is headquartered in Blue Bell, PA. | Health Technology |
| Frederick National Laboratory For Cancer Research |
- Stock Market
- Insiders
- William Rice
- Experience
